The Human Genome Project: Benefits and Risks to Society
The human genome project was initiated in 1990 to study the structure and characteristics of human DNA that are important for understanding gene functions and their relation to diseases. The large-scale genome research has driven the technology advancement in genetic testing, drug design, gene therapy, and other genetic related areas such as pharmacogenetics. Although the project reveals potential benefits, it raises ethical, legal, and social issues. The outcomes of individuals’ genetic information disclosure may lead to confidentiality and genetic discrimination issues. In addition, clinical relevance of genetic testing and psychological effect from the results are debatable. This article discusses the potential benefits and risks from the human genome project.
Key WordsHuman genome project Public policy
Unable to display preview. Download preview PDF.
- 1.Fink L, Collins FS. The human genome project: View from the National Institutes of Health. J Am Med Worn Assoc. 1997;52(1):4–7,15.Google Scholar
- 2.Cantor CR. A brief sketch of the Human Genome Project and its implications for pharmaceutical technology. Pharmaceut Tech. 1993;17:22,24,26.Google Scholar
- 3.The Human Genome Project. Revised 5-year research goals of the U.S. Human Genome Project. Human Genome News. 1993;5(4):1–5.Google Scholar
- 4.The Human Genome Project. Technology transfer—Commercializing genome resource. Human Genome News. 1995:7(3–4):15.Google Scholar
- 9.Mansfield BK. The Genome Project and the Pharmaceutical Industry. Human Genome News. 1990;2(4):1.Google Scholar
- 10.Kelloff GJ, Hawk ET, Karp JE, Crowell JA, et al. Progress in clinical chemoprevention. Sem Oncology. 1997;24(2):241–252.Google Scholar
- 12.Hildebrand CE, Stallings RL, Torney DC, Fickett JW, et al. Human genome mapping and sequencing: Applications in Pharmaceutical Science. In: Pezzuto JM, Johnson ME, Manzsse HR, Ed. Biotechnology and Pharmacy. New York: Chapman & Hall; 1993.Google Scholar
- 16.Smith TJ. Gene therapy: Opportunities for pharmacy in the 21st century. Am J Pharmaceut Educ. 1996;60:213–215.Google Scholar
- 17.Beauchamp TL, Childress JF. Principles of Biomedical Ethics. 4th ed. New York: Oxford University Press; 1994.Google Scholar
- 24.Nsiah-Jefferson L. Reproductive genetic services for low-income women and women of color: Access and sociocultural issue. In: Rothenberg KH, Thomsom EJ, eds. Women and Prenatal Testing: Facing the Challenges of Genetic Technology. Columbus, OH: Ohio State University Press; 1994.Google Scholar